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Incidence trends and clinical–pathological characteristics of
invasive cutaneous melanoma from 1980 to 2010 in the
canton of Zurich, Switzerland
Remo Mininia, Sabine Rohrmanna,b, Ralph Braunc, Dimitri Korolb and
Silvia Dehlerb
The aims of this paper are to describe the incidence trends
of invasive cutaneous melanoma in the Canton of Zurich
and to evaluate clinical and pathological factors such as
cancer subtype, localization, age and Breslow thickness.
A retrospective analysis was carried out with data from the
population-based Cancer Registry of Zurich and Zug
located in Zurich. A total of 8469 cases in 8034 different
patients of invasive cutaneous melanoma were registered
for the period 1980–2010 in the Canton of Zurich. Incidence
trends were age standardized to the European standard
population. Joinpoint regression was used to compute
changes in incidence and mortality rates, measured as the
annual percent change (APC). The most common subtypes
of cutaneous melanoma were superficial spreading
melanoma (SSM, 41.1%), followed by nodular melanoma
(16.5%), lentigo maligna melanoma (13.5%), acral-
lentiginous melanoma (5.0%) and other types of melanoma
(2.8%); 21.1% were melanoma not otherwise specified. The
trunk was the most frequent location (30.8%), followed by
the lower limb and hip (26.4%) and the upper limb and
shoulder (22.8%). Statistically significantly increasing
incidence trends were observed for both men (APC= 3.0%)
and women (APC= 2.1%). Incidences of SSM and
melanoma not otherwise specified were the histological
subtypes for which a significant increase in incidence was
observed (APC for the period 1980–2010= 3.2% for both).
In terms of Breslow thickness, thin melanomas
(0.01–1.00mm) showed an increasing incidence. The
incidence of melanoma increased in both men and women
between 1980 and 2010. In terms of the different subtypes
and Breslow thickness, increasing incidences of the SSM
and of thin melanomas (0.01–1.00mm) were observed.
These observations are in agreement with other studies
from Southern and Western Switzerland as well as other
European countries and the USA. Melanoma Res
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Introduction
Melanoma is a relevant and emerging problem in
Switzerland. In 2012, Switzerland was ranked third place
among the countries with the highest incidence of
melanoma with only Australia and New Zealand had
higher incidence rates [1–3]. Assumed risk factors in
those two countries are the fair-skinned population,
proximity to the equator and ozone layer depletion [4].
There are almost no cases in black and Asian populations,
except that they have the same incidence of acral-lenti-
ginous melanoma as Caucasians [1–3,5]. In 2012 in
Europe, Switzerland was the country with the highest
incidence rates, followed by the Scandinavian countries
and the Netherlands [1]. The lowest incidence rates are
found in Mediterranean countries because of the darker
skin type of the population and different sun-exposure
behaviour [1–3]. The incidence is higher among women
than among men [1]. Mortality rates are the highest in
Norway and Slovenia; Switzerland is ranked sixth [1].
Melanoma is the fourth most common cancer in
Switzerland and it has the highest increase in incidence of
all cancer types in recent years [6]. The incidence is
slightly higher in the French-speaking part of
Switzerland, but the incidence in the German-speaking
part is increasing and catching up [7]. Early detection
leads to increased incidence of thin, but not thick and
aggressive, fast-growing melanoma [8]. As a consequence,
the mortality rate remains unchanged in Switzerland [6–8]
because thin melanomas have a higher survival and a
lower mortality rate [8]. Two main risk factors are
assumed to be responsible for the increase in the inci-
dences of melanoma in Switzerland and worldwide:
increased exposure to the sun and increased dermatolo-
gical consultations, leading to greater awareness and more
consultations. The increased exposure to ultraviolet (UV)
radiation can be explained by three main reasons: holidays
in sunny/warm destinations, more frequent outdoor
activities and increased use of sunbeds [6,8,9].
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Prevention is a highly important factor in reducing the
risk of having a melanoma. The most important action is
to avoid UV radiation, especially from 10 a.m. to 4 p.m.
[6,10]. There are several strategies to protect oneself
from UV radiation such as actively seeking shade, cov-
ering up and last, but not least, using sunscreen. As the
risk of having a melanoma increases with sunburn in
childhood, it is highly necessary to avoid it [6,10].
Individuals with a higher melanoma risk than the average
population because of a positive family history, one or
more melanomas diagnosed in the past or several nevi are
recommended to consult a dermatologist and have their
integument examined at least every year [10].
The aims of this paper are to describe the incidence
trends of the invasive cutaneous melanoma in the Canton
of Zurich between 1980 and 2010, and, furthermore, to
evaluate changes with respect to clinical and pathological
factors such as cancer subtype, localization, age and
Breslow thickness.
Patients and methods
A retrospective analysis was carried out with data from
the population-based Cancer Registry of Zurich and Zug
located in Zurich. A total of 8469 cases of invasive cuta-
neous melanoma [defined as site C44 using the third
edition of the International Classification of Diseases for
Oncology (ICD-O-3) [11]] in 8034 different patients were
registered for the period 1980–2010 in the Canton of
Zurich.
The cancer registry has collected data since 1980. It
registers every patient whose registered residence is in
the Canton of Zurich and Zug (since 2011) at the point of
diagnosis [12].
The histological subtypes were classified using ICD-O-3
codes as follows: superficial spreading melanoma (SSM,
8743), nodular melanoma (NM, 8721), lentigo maligna
melanoma (LMM, 8742), acral-lentiginous melanoma
(ALM, 8744), other types of melanoma (OTM, 8722,
8723, 8730, 8740, 8741, 8745, 8761, 8770, 8771, 8772,
8780) and melanoma not otherwise specified (MNOS,
8720) [11,13,14].
Tumour localization was classified using ICD-O-3 codes
using the following localizations: head and neck
(C440–C444), trunk (C445), upper limb and shoulder
(C446), lower limb and hip (C447), more than one local-
ization (C448) and unknown localization (C449) [14].
Breslow thickness was classified according to the TNM
classification using the following categories: 0.01–1.00;
1.01–2.00; 2.01–4.00; > 4.00 and unknown Breslow
thickness [15].
Statistical analysis: incidence rates were calculated per
100 000 person-year. All rates are standardized to the
European population using the direct method [16]. To
assess changes in incidence, we computed the annual
percent change (APC) of the standardized rates using
joinpoint regression [17,18].
To examine differences in the clinical–pathological
characteristics, the Pearson χ2-test was used to examine
differences among the melanoma subtypes for discrete
variables such as sex, location, Breslow thickness cate-
gories and periods. Furthermore, the Scheffe test was
used to compare the median age among the melanoma
subtypes. P-values less than 0.05 were considered stat-
istically significant. In general, analyses of incidence were
carried out at the patient level, whereas calculations of
melanoma-specific factors were performed at the
case level.
Results
In the period 1980–2010, a total of 8469 documented
cases of malignant melanoma were registered in the
canton of Zurich by the Cancer Registry of Zurich
and Zug.
The most frequent histological subtype was the SSM
type (41%), followed by the NM type (16%) and the
LMM type (14%). About 21% of all cases were not his-
tologically classified (Table 1). There was a slightly
higher incidence among female patients (51.5%) than in
male patients (48.5%). Differences in histological sub-
type and sex were statistically significant (P< 0.001),
with the biggest difference being observed in the ALM
subtype (women 67%), followed by the OTM subtype
(women 56%), the NM subtype (men 55%) and the SSM
subtype (women 53%).
LMM had the highest median age at diagnosis (70 and
72 years, respectively) and SSM had the lowest median
age at diagnosis (55 years). Differences between the
mean and the median age and histological subtype were
statistically significant (P< 0.001) (Table 1).
Most melanomas were located on the trunk (31%), fol-
lowed by the lower limb and hip (26%), upper limb and
shoulder (23%) and head and neck (18%) (Table 1).
There were statistically significant differences between
location and histological subtype (P< 0.001). About 50%
of the head and neck melanomas were of the LMM
subtype, whereas ALM and OTM subtypes were most
frequently located on the lower limb, and the trunk was
the preferred location for SSM, NM and MNOS.
About 60% of all skin melanoma cases had a Breslow
thickness of 0.01–1.00 mm. A Breslow thickness of
0.01–1.00 mm was the most frequent in all of the sub-
types, except for NM, for which it was 2.01–4.00 mm
(Table 1). Almost half of all melanoma cases (46.3%)
were registered in the period from 2001 to 2010, about
one-third (31%) from 1991 to 2000 and about a fifth
(22.67%) from 1980 to 1990 (Table 1).
APC and corresponding P-values were computed for the
periods 1980–2010, 1980–1990, 1991–2000 and 2001–2010.
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Generally, the incidence of malignant melanoma increased
significantly between 1980 and 2010 in both men (APC:
3.02%) and women (APC: 2.1%). The highest significant
increase was observed in the period from 1980 to 1990 in
both men (APC: 7.24%) and women (APC: 5.49%)
(Table 2 and Fig. 1).
Observing the histological types in the period 1980–2010,
there was an increasing incidence in SSM (APC: 3.24%),
LMM (APC: 2.22%) and MNOS (APC: 3.24%), with
statistical significance for SSM and MNOS. The inci-
dence of the SSM subtype increased significantly in the
period 1980–1990 (APC: 6.46%) and from 2001 to 2010
(APC: 7.44%). Constant incidence trends were observed
for NM, ALM and OTM subtypes, although in the
period from 1980 to 1990, a large significant increase was
observed for NM (APC: 3.09%) and ALM (APC:
24.52%). About 92% of ALM cases were located on the
limbs (391 cases), 7% were located on the trunk and head
and neck (36 cases) and 1% had no specific location
(three cases) (Table 2 and Fig. 2).
In terms of the location, a statistically significant APC was
observed in all four locations between 1980 and 2010,
with the highest increase in the upper limb and shoulder
(APC: 3.57%) and the lowest increase in the lower limb
and hip (APC: 1.98%). Statistically significantly increas-
ing trends were mainly observed between 1980 and 1990
for the trunk (APC: 6.82%), upper limb and shoulder
(APC: 8.31%) and the lower limb and hip (APC: 5.55%),
but hardly in the following two decades. Only the inci-
dence of the upper limb and shoulder increased statis-
tically significantly in the period 2001–2010 (APC: 9.8%).
A statistically significant increase was also observed in
sun-exposed areas such as the head and neck (APC:
2.58%) (Table 2 and Fig. 3).
Table 1 Clinical–pathological characteristics of melanoma patients from the canton of Zurich diagnosed between 1980 and 2010
Total SSM NM LMM ALM OTM MNOS P-value
Number 8469 3482 1393 1143 427 235 1789
Percent 41.1 16.5 13.5 5 2.8 21.1
Sex (%) <0.001
Male 48.6 47 55.9 49.1 33.5 43.8 49.9
Female 51.4 53 44.1 50.9 66.5 56.2 50.1
Age (years) <0.001
Median 60.3 55.1 65 71.6 58.7 62.5 58.7
25th percentile 45.4 42.2 50.9 62.5 42.3 45.4 44.3
75th percentile 72.7 67.5 77.3 79.3 71.3 73.9 72.6
Location (%) <0.001
Head and neck 17.5 7.5 19.1 53.1 2.8 16.6 16.7
Trunk 30.8 37.9 28.3 19.7 4.9 25.1 33
Upper limb and shoulder 22.8 25.6 26.1 16.3 19 20 20.1
Lower limb and hip 26.4 28.1 25.8 9.3 72.6 29.4 22.8
Multiple locations 0.01 0 0 0 0 0 0.1
Not otherwise specified 2.5 0.9 0.7 1.6 0.7 8.9 7.3
Breslow thickness (mm) (%) <0.001
0–1.00 60 79 10.2 82.2 52.7 37.4 52.5
1.01–2.00 16.5 14.8 26.9 9 19.7 14.9 15.9
2.01–4.00 10.9 4.1 36.6 4.2 17.3 9.4 7
>4.00 6.1 1.3 23.8 1.4 7.3 9.8 3.8
Unknown 6.5 0.8 2.5 3.2 3 28.5 20.8
Period (%) <0.001
1980–1990 22.7 20.1 28.8 21.3 24.8 22.5 23.2
1991–2000 31 33.1 31.9 33.2 33.7 34.5 23.8
2001–2010 46.3 46.8 39.3 45.5 41.5 43 53
ALM, acrolentiginous melanoma; LMM, lentigo maligna melanoma; MNOS, melanoma not otherwise specified; NM, nodular melanoma; OTM, other type of melanoma;
SSM, superficial spreading melanoma.
Table 2 Incidence trends of melanoma according to sex, subtype,
size and location by time period in percent expressed as annual
percent change
Periods
Subgroups 1980–2010 1980–1990 1991–2000 2001–2010
Sex
Male 3.02* 7.24* −0.59 3.78*
Female 2.10* 5.49* 1.1 3.21
Subtype
SSM 3.24* 6.46* −2.2 7.44*
LMM 2.22 6.66* −2.91 3.05*
NM 0.41 3.09* 0.9 −2.78
ALM 0.8 24.52* 9.2 −8.98
OTM 0.32 11.42 −9.45 −6.24
MNOS 3.24* 2.46 4.30* 3.38*
Location
Head and neck 2.58* 2.68 −2.91 3.05
Trunk 2.12* 6.82* −1.77 −2.09
Upper limb and
shoulder
3.57* 8.31* 0.38 9.80*
Lower limb and hip 1.98* 5.55* 0.48 2.85
Breslow thickness (mm)
≤1.00 3.49* 8.27* −0.97 4.67*
1.01–2.00 1.61* −2.8 6.92 −4.81*
2.01–4.00 0.4 2.38 −0.28 1.41
>4.00 0.72 11.18* −1.17 1.3
Unknown 0.57 −2.8 6.92 −4.81*
ALM, acrolentiginous melanoma; LMM, lentigo maligna melanoma; MNOS,
melanoma not otherwise specified; NM, nodular melanoma; OTM, other type of
melanoma; SSM, superficial spreading melanoma.
*Statistically significant difference (P<0.05).
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Observing the Breslow thickness, there was a statistically
significant increase in malignant melanomas with a
thickness of 1.00 mm or less (APC: 3.49%) and melan-
omas with a thickness of more than 1.00 mm and up to
2.00 mm (APC: 1.61%) from 1980 to 2010, whereas the
incidence of melanomas with a thickness of more than
2.00 or with an unknown thickness remained almost
constant. From 2001 to 2010, a statistically significant
decreasing incidence was observed for melanomas with a
thickness more than 1.00 mm and 2.00 mm or less (APC:
− 4.81%) and for melanomas with an unknown thickness
(APC: −4.81%) (Table 2 and Fig. 4).
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Discussion
In our analysis of data assessed in the Swiss Canton of
Zurich, we observed increasing incidences of malignant
melanomas in men and women between 1980 and 2010,
especially in the period 1980–1990. Studies from
Southern and Western Switzerland and other countries
also reported an increase in the last few years and
decades, especially in European countries such as
Norway, Sweden, the Netherlands and Ukraine as well as
the USA and Australia [19–28]. Despite the observation
of a marked increase in incidence between 1980 and
1990, almost half of the cases are in the period of
2001–2010. This corresponds with the current opinion
that the incidence of melanoma is still increasing.
Fig. 3
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Overall, there were almost as many cases among men as
in women, in agreement with the literature [27,29].
However, large sex-related differences were observed in
the acrolentiginous subtype. In another study, similar
incidence rates of these subtypes were found on com-
paring men and women in an analysis of US data [5].
Location analysis with the trunk as the most frequent
location, followed by the lower limb and hip also corre-
sponds with the literature, in which the trunk is the most
frequent location in men and the lower limb and hip are
the most frequent locations in women [20,23,27,29,30].
We expected that more than half of all LMM cases were
located in the head and neck area as it is a subtype of the
melanoma that occurs in places with high UV exposures
over time such as the face and the neck [29]. An extra-
ordinary observation was ALM cases located on the trunk
and on the head and neck as ALM is, by definition,
strictly located subungual, palmar or plantar [29]. A pos-
sible reason for these errors may be an inaccurate histo-
logical diagnosis. Otherwise, there could have been a
wrong understanding of the term ‘acrolentiginous’ in
these cases. In medical language, the term ‘acral’ is not
only used for fingers and toes, but for other peripheral
body parts such as the ears and nose. For example, a
lentigo maligna melanoma on the nose could have been
mistaken for an acrolentiginous melanoma. In the 1980s,
there was a significant increase in the incidence of
melanoma located on the trunk, upper and lower limb,
whereas from 2001 to 2010, only melanoma incidence
located on the upper limb increased significantly. A slight
decrease was observed in melanomas of the trunk from
2001 to 2010. The increase in cases on the shoulders and
upper limb in recent years has not been observed in other
studies. We do not have a valid explanation for this
observation, but it might be associated with leisure time
and sun-bathing activities of individuals living in the
canton of Zurich.
SSM was the most frequent subtype observed in the
Zurich cancer registry, followed by NM, LMM and ALM,
which is in agreement with the literature [20,29,31]. In our
study, about 20% of all cases were ‘melanomas, not
otherwise specified’, a similar percentage as in Southern
Switzerland [20].
SSM is the only specific subtype with a significant
increase in APC between 1980 and 2010, which corre-
sponds to similar results from Southern and Western
Switzerland [20,25]. In addition, we observed a sig-
nificant increase in MNOS from 1980 to 2010; a study
from the USA showed similar results [32].
In terms of Breslow thickness, most cases are in the
category of 0.01–1.00 mm. This is also the only category
for which we observed a significant increase in incidence
between 2001 and 2010. The incidence rates of other
categories remained almost constant or even decreased;
as Breslow thickness is an important factor predicting
prognosis, these rates possibly explain the constant
mortality rates in Switzerland [4]. Similar results were
observed in Southern Switzerland and Italy [20,24].
These results may be explained by the increased
awareness and, thus, early detection. NM is a very
aggressively growing form of melanoma; therefore, high
percentages were found in the categories 2–4 and more
than 4 mm compared with all other types. Both LMM
and SSM have a very high percentage in the
0.01–1.00 mm category. A possible reason for this may be
the superficial growth of these subtypes.
The median age at diagnosis was 60.3 years. It was the
highest in patients with LMM; LMM usually develops
from a lentigo maligna, a melanoma in situ occurring in
sun-damaged skin [29]. In contrast, patients with the
SSM or the ALM subtype were younger at diagnosis.
Similar numbers and results have been found in other
studies [20,29].
A strength of the data is the long time period, during
which the data were registered, which allowed us to
observe and analyse the incidence trends over 30 years.
Another strength of the data set is the amount of infor-
mation that it provides such as location, subtype and
Breslow index or the distinction between melanoma
in situ and invasive melanoma. With this information, we
could carry out a precise analysis of different key aspects.
A limitation is the partially missing data on mortality,
which would allow for computation of survival rates.
Another limitation is that one-fifth of all melanomas were
not histologically specified. The reasons for this may be
case registration problems or the impossibility of identi-
fication of the subtype histologically. A limitation that is
common to many evaluations of epidemiological cancer
registries is the fact that we cannot examine risk factors
such as family history of melanoma, skin type nor sun-
bathing behaviour of malignant melanomas with our
database.
Conclusion
In the Swiss Canton of Zurich, the incidence of melan-
oma has increased over the last 30 years in both men and
women. In particular, we observed an increasing inci-
dence of SSM and thin melanomas (0.01–1.00 mm).
These observations are in agreement with studies from
Southern and Western Switzerland as well as other
European countries and the USA [33]. The reasons for
this may be the increased awareness of melanoma in the
community, which leads to more frequent dermatologist
consultations and earlier detection. To decrease the
incidence rates, there is still a need for education on the
causes of cutaneous melanoma, especially the danger of
UV radiation.
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